DOCSLIB.ORG

Kidneyseq™ V4 – 312 Genes CAKUT Branchiooculofacial Syndrome AD

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Kidneyseq™ V4 – 312 Genes CAKUT Branchiooculofacial Syndrome AD KidneySeq™ v4 – 312 Genes Ciliopathies/tubulointerstitial diseases Disorders of tubular ion transport CAKUT Autosomal dominant tubulo interstitial disease (AD) Cystinosis Branchiooculofacial syndrome AD: HNF1B, REN, UMOD AR: CTNS AD: TFAP2A Bardet-Biedl syndrome (BBS) Cystinuria Branchio-oto-renal syndrome AR: ARL6, BBIP1, BBS2, BBS4, BBS5, BBS7, BBS10, BBS12, C8orf37, AD & AR: SLC3A1, SLC34A1, SLC7A9 AD: EYA1, SIX1, SIX5 CEP290, IFT27, IFT74, LZTFL1, MKKS, PTHB1, SDCCAG8, TRIM32, Dent disease CAKUT with VACTERL TTC8, WDPCP XLR: CLCN5, OCRL AR: TRAP1 AR & DR: BBS1 Familial juvenile hyperuricemic nephropathy – 4 CHARGE syndrome COACH syndrome (JN+) AD: SEC61A1 AD: CHD7, SEMA3E AR: CC2D2A, RPGRIP1L, TMEM67 Fanconi-Bickel syndrome Cogan oculomotor apraxia HANAC syndrome AR: SLC2A2 AR: NPHP1 AD: COL4A1 Fanconi syndrome, generalized proximal defect Common CAKUT Hypokalemic-alkalotic salt-losing nephropathy AD: EHHADH, HNF4A AD: ACTG1, AGTR1, CHD1L, DLG1, DSTYK, ETV4, EYA1, FOXP1, CLDN10 AR: ATP7B, CTNS, FAH, GATM, SLC34A1 GATA3, GDNF, GREB1L, HNF1B, KAT6B, KIF12, KMT2D, NRIP1, Interstitial nephritis, karyomegalic XLR: CLCN5 PAX2, PBX1, RET, ROBO2, SALL1, SIX2, SIX5, SLIT2, SRGAP1, AR: FAN1 Gitelman syndrome TBX18, Jeune syndrome (JN+) AR: CLCNKB, SLC12A3 AR: CTU2, FAT4, HPSE2, TRAP1, TRPS1 AR: IFT80, IFT140, DYNC2H1, NEK1, TTC21B Glucosuria, renal Fraser syndrome Joubert syndrome (JN+) AR & AD: SLC5A1, SLC5A2 AR: FRAS1, FREM1, FREM2, GREM1, GRIP1 AR: AHI1, ARL13B, ARMC9, ATXN10, C2CD3, C5orf42, CC2D2A, Hypoaldosteronism, congenital Genitopatellar syndrome CEP104, CEP290, CEP41, CFAP410, CSPP1, IFT172, INPP5E, AR: CYP11B2 AD: KAT6B KIAA0556, KIF7, NPHP1, OFD1, RPGRIP1L, TCTN1, TCTN3, Hypomagnesemia, renal Hypoparathyroidism, sensorineural deafness, and renal dysplasia TMEM138, TMEM216, TMEM237, TMEM67, TTC21B AD: CNNM2, FXYD2 AD: GATA3 AD & AR: ZNF423 AR: CLDN16, CLDN19, EGF, HNF1B, TRPM6 Isolated renal hypo-dysplasia Juvenile nephronophthisis (JN) Hyperaldosteronism, familial AD: BMP4, DSTYK, HNF1B, PAX2, RET, SALL1, SIX2 AR: AHI1, ANKS6, ATXN10, IQCB1, CEP164, CEP290, CEP83, DCDC2, AD: CACNA1D, CACNA1H, CLCN2, CYP11B1, KCNJ5 AR: DACH1, FGF20, ITGA8, GLIS2, INVS, MAGI2, MAPKBP1, NEK8, NPHP1, NPHP3, NPHP4, Hyperaldosteronism, glucocorticoid remediable RPGRIP1L, SLC41A1, TMEM67, TTC21B, WDR19, XPNPEP3 Isolated renal hypoplasia: renal adysplasia AD: CYP11B1-CYP11B2 fusion AD &AR: ZNF423 AR: RET, UPK3 Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis Meckel syndrome (MKS)/Meckel-Gruber syndrome (JN+) Hypogonadotropic hypogonadism with or without anosmia (Kallmann syndrome (HUPRAS) AR: B9D1, B9D2, CC2DA, CEP290, KIF14, MKS1, NPHP3, RPGRIP1L, syndrome) AR: SARS2 TCTN2, TMEM107, TMEM216, TMEM237, TMEM67 AD: CHD7, FGFR1 Hypercalciuria XL: ANOS1 Medullary cystic kidney disease 2 AD: ADCY10 AD: UMOD Mayer-Rokitansky-Küster-Hauser syndrome Hyperoxaluria, primary AD: WNT4 Orofaciodigital syndrome 1 AR: AGXT, GRHPR, HOGA1 XLD: OFD1 Multicystic dysplastic kidney Hypertension with hyperkalemia (Gordon's syndrome), AD: CHD1L, HNF1B, ROBO2, SALL1 Polycystic kidney disease, autosomal recessive (ARPKD) Pseudohypoaldosteronism II AR: DZIP1L, PKHD1 Posterior urethral valves AD: CUL3, WNK1, WNK4 AD: CHD1L, HNF1B, ROBO2, SALL1, SIX2 Polycystic kidney disease, autosomal dominant (ADPKD) AR: KLHL3 AD: GANAB, HNF1B, NOTCH2, OFD1, PKD1, PKD2 Renal-Coloboma syndrome Hypocalcemia, autosomal dominant AR: PAX2 Renal cysts and diabetes syndrome AD: CASR AD: HNF1B Renal cysts and diabetes syndrome Hypokalemic-alkalotic salt-losing nephropathy AD: HNF1B Serpentine fibula with polycystic kidney disease (SFPKS)/ Hajdu-Cheney AR: CLCN10 syndrome (HJCYS) Renal fibrosis Hypophosphatemic rickets AD: NOTCH2 AD: PARN AD: FGF23 Sensenbrenner syndrome/Cranioectodermal dysplasia (CED) Renal tubular dysgenesis AR: DMP1, CYP27B1, ENPP1, SLC34A3, VDR AR: IFT122, IFT43, WDR19, WDR35 AR: ACE, AGT, AGTR1, REN XLR: CLCN5, PHEX Senior-Loken syndrome- (JN with retinitis pigmentosa) Townes-Brocks syndrome Hypouricemia, renal AR: CEP290, IQCB1, NPHP1, NPHP3, NPHP4, SDCCAG8, WDR19 AD: SALL1 AD: SLC2A9 Unilateral renal agenesis Disorders of tubular ion transport AR: SLC22A12 AD: DSTYK, HNF1B, RET, SALL1 Adrenal hyperplasia, congenital (11b-OH deficiency) Liddle syndrome (AD) (pseudoprimary hyperaldosteronism) UPJ obstruction AR: CYP11B1 AD: SCNN1B, SCNN1G AD: DSTYK, EYA1, HNF1B, RET, ROBO2, SALL1 Apparent mineralocorticoid excess, syndrome of Nephrogenic diabetes insipidus UVJ obstruction AR: HSD11B2 AD & AR: AQP2 AD: CHD1L, PAX2, SIX5 APRT deficiency (stones and ESRD) XLR: AVPR2 Vesicoureteral reflux AR: APRT Nephrogenic syndrome of inappropriate antidiuresis AD: DSTYK, EYA1, GATA3, HNF1B, RET, ROBO2, SALL1, SOX17, Bartter syndrome XLR: AVPR2 TNXB, UPK3A AD: CaSR Nephrolithiasis/osteoporosis, hypophosphatemic Alagille syndrome AR: BSND, CLCNKA, CLCNKB, KCNJ1, MAGED2, SLC12A1 AD: SLC9A3R1 AD: JAG1, NOTCH2 Disorders of tubular ion transport Glomerular diseases Nephrolithiasis/nephrocalcinosis Pseudohypoaldosteronism I Focal segmental glomerulosclerosis (FSGS) with Duane retraction Nephrolithiasis/osteoporosis, hypophosphatemic AD: NR3C2 syndrome AD: SLC9A3R1 AR: SCNN1A, SCNN1B, SCNN1G AD: MAFB Renal tubular acidosis, distal Renal tubular acidosis, distal Galloway-Mowat syndrome AD & AR: ATP6V0A4, ATP6V1B1, SLC4A1 AD & AR: ATP6V0A4, ATP6V1B1, FOXI1, SLC4A1 AR: NUP133, OSGEP, TP53RK, TPRKB, WDR73 Renal tubular acidosis, proximal Renal tubular acidosis, proximal XLR: LAGE3 AD: EHHADH, HNF4A AD: EHHADH, HNF4A Glomerulopathy with fibronectin deposits AR: CTNS FAH, SLC34A1, SLC4A4 AR: ATP7B, CTNS, FAH, SLC34A1, SLC4A4 AD: FN1 XR: ATP7B, CLCN5 XLR: CLCN5 Infantile sialic acid storage disease Xanthine oxidase deficiency Renal tubular acidosis, type IV AR: SLC17A5 AR: XDH AD: CUL3, KLHL3, NR3C2, WNK1, WNK4 Lipodystrophy, familial, partial Other AR: SCNN1A, SCNN1B, SCNN1G AD: LMNA Arthrogryposis, renal dysfunction Renal tubular acidosis, with osteopetrosis Lipoprotein glomerulopathy AR: VIPAS39, VPS33B AR: CA2 APOE Charcot-Marie Tooth disease (CMTDIE) Renal tubular disease, hypertension related Muckle-Wells syndrome AD: INF2 NEDD4L AD: NLRP3 CHARGE syndrome SESAME syndrome / East syndrome Nail patella syndrome AD: CHD7, SEMA3E AR: KCNJ10 AD: LMX1B Duane-radial ray syndrome (Okihiro syndrome) Glomerular diseases Nephropathy with pretibial epidermolysis bullosa and deafness AD: SALL4 Alport syndrome AR: CD151 Finlay-Marks syndrome AR: COL4A4 Nephrotic syndrome - steroid sensitive AD: KCTD1 AD & AR: COL4A3 PLCG2 Lesch-Nyhan syndrome XLD: COL4A5 Pierson syndrome - nephrotic syndrome with microcoria XLR: HPRT1 XLR: COL4A6 AR: LAMB2 Hypercalcemia, infantile Alstrom syndrome Thin basement membrane disease (benign familial hematuria) AR: CYP24A1 AR: ALMS1 AD: COL4A3, COL4A4 Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis Amyloidosis, hereditary Nephrolithiasis/nephrocalcinosis syndrome (HUPRAS) AD: APOA1, B2M, FGA, GSN, LYZ, NLRP3, TNFRSF1A, TTR APRT deficiency (stones and ESRD) AR: SARS2 Congenital lung disease, nephrotic syndrome and mild epidermolysis AR: APRT Mitochondrial cytopathies bullosa Bartter syndrome AR: COQ2 AR: ITGA3 AD: CaSR Pallister-Hall syndrome Congenital nephrotic syndrome (Finnish type) AR: KCNJ1, SLC12A1 AD: GLI3 AR: NPHS1 Cystinuria Rubinstein-Taybi syndrome COQ2 nephropathy AD & AR: SLC3A1, SLC34A1, SLC7A9 AD: CREBBP AR: COQ2 Dent disease Schimke immuno-osseus dysplasia Denys-Drash syndrome; Frasier syndrome XLR: CLCN5, OCRL AR: SMARCAL1 AD: WT1 Fanconi syndrome, generalized proximal defect SERKAL syndrome – 46XX sex reversal with dysgenesis of kidneys, Diffuse mesangial sclerosis AD: EHHADH, HNF4A adrenal and lungs AR: ARHGDIA, PLCE1, WT1 AR: ATP7B, CTNS, FAH, SLC34A1 AR: WNT4 Epstein/Fechtner - renal disease with macrothrombocytopenia XR: CLCN5 SESAME syndrome / East syndrome AD: MYH9 Hypomagnesemia with hypercalciuria AR: KCNJ10 Fabry disease AR: CLDN16, CLDN19 Simpson-Golabi-Behmel syndrome XL: GLA Hypercalcemia, infantile XLR: GPC3 Familial lecithin cholesterol acyltransferase (LCAT) deficiency AR: CYP24A1 Smith-Lemli-Optiz syndrome AR: LCAT Hypercalciuria AR: DHCR7 Familial Mediterranean Fever AD: ADCY10 Tuberous sclerosis AD&AR: MEFV Hyperoxaluria, primary AD: TSC1, TSC2 Focal segmental glomerulosclerosis (FSGS) AD/XL AR: AGXT, GRHPR, HOGA1 von Hippel-Landau syndrome – familial cancer syndrome AD: ACTN4, ANLN, ARHGAP24, CD2AP, CFI, COL4A3, COL4A4, E2F3, Hypocalcemia, autosomal dominant AD: VHL INF2, LMX1B, PAX2, TRPC6, WT1 AD: CASR Williams-Beuren syndrome XL: COL4A5 Hypophosphatemic rickets AD: 7q 11.23 Focal segmental glomerulosclerosis (FSGS) AR AD: FGF23 Xanthine oxidase deficiency AR: APOL1, COQ6, CRB2, ITGB4, LAMA5, MYO1E, NPHP4, NUP133, AR: DMP1, ENPP1, SLC34A3, VDR AR: XDH NUP160, NUP85, TTC21B XLR: CLCN5, PHEX Focal segmental glomerulosclerosis (AR)/SRNS Hypouricemia, renal AR: ADCK4, ALG1, ANKFY1, ARHGDIA, CUBN, DGKE, DHTKD1, DLC1, AD: SLC2A9 EMP2, FAT1, GAPVD1, LAMB2, NPHS1, NPHS2, NUP107, NUP205, AR: SLC22A12 NUP93, PLCE1, PDSS2, PMM2, PTPRO, SCARB2, SGPL1, XPO5, Lesch-Nyhan syndrome ZMPSTE24 XLR: HPRT1 .
Load more

Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • Educational Paper Ciliopathies
    Eur J Pediatr (2012) 171:1285–1300 DOI 10.1007/s00431-011-1553-z REVIEW Educational paper Ciliopathies Carsten Bergmann Received: 11 June 2011 /Accepted: 3 August 2011 /Published online: 7 September 2011 # The Author(s) 2011. This article is published with open access at Springerlink.com Abstract Cilia are antenna-like organelles found on the (NPHP) . Ivemark syndrome . Meckel syndrome (MKS) . surface of most cells. They transduce molecular signals Joubert syndrome (JBTS) . Bardet–Biedl syndrome (BBS) . and facilitate interactions between cells and their Alstrom syndrome . Short-rib polydactyly syndromes . environment. Ciliary dysfunction has been shown to Jeune syndrome (ATD) . Ellis-van Crefeld syndrome (EVC) . underlie a broad range of overlapping, clinically and Sensenbrenner syndrome . Primary ciliary dyskinesia genetically heterogeneous phenotypes, collectively (Kartagener syndrome) . von Hippel-Lindau (VHL) . termed ciliopathies. Literally, all organs can be affected. Tuberous sclerosis (TSC) . Oligogenic inheritance . Modifier. Frequent cilia-related manifestations are (poly)cystic Mutational load kidney disease, retinal degeneration, situs inversus, cardiac defects, polydactyly, other skeletal abnormalities, and defects of the central and peripheral nervous Introduction system, occurring either isolated or as part of syn- dromes. Characterization of ciliopathies and the decisive Defective cellular organelles such as mitochondria, perox- role of primary cilia in signal transduction and cell isomes, and lysosomes are well-known
    [Show full text]
  • Reframing Psychiatry for Precision Medicine
    Reframing Psychiatry for Precision Medicine Elizabeth B Torres 1,2,3* 1 Rutgers University Department of Psychology; [email protected] 2 Rutgers University Center for Cognitive Science (RUCCS) 3 Rutgers University Computer Science, Center for Biomedicine Imaging and Modelling (CBIM) * Correspondence: [email protected]; Tel.: (011) +858-445-8909 (E.B.T) Supplementary Material Sample Psychological criteria that sidelines sensory motor issues in autism: The ADOS-2 manual [1, 2], under the “Guidelines for Selecting a Module” section states (emphasis added): “Note that the ADOS-2 was developed for and standardized using populations of children and adults without significant sensory and motor impairments. Standardized use of any ADOS-2 module presumes that the individual can walk independently and is free of visual or hearing impairments that could potentially interfere with use of the materials or participation in specific tasks.” Sample Psychiatric criteria from the DSM-5 [3] that does not include sensory-motor issues: A. Persistent deficits in social communication and social interaction across multiple contexts, as manifested by the following, currently or by history (examples are illustrative, not exhaustive, see text): 1. Deficits in social-emotional reciprocity, ranging, for example, from abnormal social approach and failure of normal back-and-forth conversation; to reduced sharing of interests, emotions, or affect; to failure to initiate or respond to social interactions. 2. Deficits in nonverbal communicative behaviors used for social interaction, ranging, for example, from poorly integrated verbal and nonverbal communication; to abnormalities in eye contact and body language or deficits in understanding and use of gestures; to a total lack of facial expressions and nonverbal communication.
    [Show full text]
  • Ciliopathiesneuromuscularciliopathies Disorders Disorders Ciliopathiesciliopathies
    NeuromuscularCiliopathiesNeuromuscularCiliopathies Disorders Disorders CiliopathiesCiliopathies AboutAbout EGL EGL Genet Geneticsics EGLEGL Genetics Genetics specializes specializes in ingenetic genetic diagnostic diagnostic testing, testing, with with ne nearlyarly 50 50 years years of of clinical clinical experience experience and and board-certified board-certified labor laboratoryatory directorsdirectors and and genetic genetic counselors counselors reporting reporting out out cases. cases. EGL EGL Genet Geneticsics offers offers a combineda combined 1000 1000 molecular molecular genetics, genetics, biochemical biochemical genetics,genetics, and and cytogenetics cytogenetics tests tests under under one one roof roof and and custom custom test testinging for for all all medically medically relevant relevant genes, genes, for for domestic domestic andand international international clients. clients. EquallyEqually important important to to improving improving patient patient care care through through quality quality genetic genetic testing testing is is the the contribution contribution EGL EGL Genetics Genetics makes makes back back to to thethe scientific scientific and and medical medical communities. communities. EGL EGL Genetics Genetics is is one one of of only only a afew few clinical clinical diagnostic diagnostic laboratories laboratories to to openly openly share share data data withwith the the NCBI NCBI freely freely available available public public database database ClinVar ClinVar (>35,000 (>35,000 variants variants on on >1700 >1700 genes) genes) and and is isalso also the the only only laboratory laboratory with with a a frefree oen olinnlein dea dtabtaabsaes (eE m(EVmCVlaCslas)s,s f)e, afetuatruinrgin ag vaa vraiarniatn ctl acslasisfiscifiactiaotino sne saercahrc ahn adn rde rpeoprot rrte rqeuqeuset sint tinetrefarcfaec, ew, hwichhic fha cfailcitialiteatse rsa praidp id interactiveinteractive curation curation and and reporting reporting of of variants.
    [Show full text]
  • KAT6A Syndrome: Genotype-Phenotype Correlation in 76 Patients with Pathogenic KAT6A Variants
    KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants. Item Type Article Authors Kennedy, Joanna;Goudie, David;Blair, Edward;Chandler, Kate;Joss, Shelagh;McKay, Victoria;Green, Andrew;Armstrong, Ruth;Lees, Melissa;Kamien, Benjamin;Hopper, Bruce;Tan, Tiong Yang;Yap, Patrick;Stark, Zornitza;Okamoto, Nobuhiko;Miyake, Noriko;Matsumoto, Naomichi;Macnamara, Ellen;Murphy, Jennifer L;McCormick, Elizabeth;Hakonarson, Hakon;Falk, Marni J;Li, Dong;Blackburn, Patrick;Klee, Eric;Babovic- Vuksanovic, Dusica;Schelley, Susan;Hudgins, Louanne;Kant, Sarina;Isidor, Bertrand;Cogne, Benjamin;Bradbury, Kimberley;Williams, Mark;Patel, Chirag;Heussler, Helen;Duff- Farrier, Celia;Lakeman, Phillis;Scurr, Ingrid;Kini, Usha;Elting, Mariet;Reijnders, Margot;Schuurs-Hoeijmakers, Janneke;Wafik, Mohamed;Blomhoff, Anne;Ruivenkamp, Claudia A L;Nibbeling, Esther;Dingemans, Alexander J M;Douine, Emilie D;Nelson, Stanley F;Arboleda, Valerie A;Newbury-Ecob, Ruth DOI 10.1038/s41436-018-0259-2 Journal Genetics in medicine : official journal of the American College of Medical Genetics Download date 30/09/2021 21:53:13 Link to Item http://hdl.handle.net/10147/627191 Find this and similar works at - http://www.lenus.ie/hse HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Genet Med Manuscript Author . Author manuscript; Manuscript Author available in PMC 2019 October 01. Published in final edited form as: Genet Med. 2019 April ; 21(4): 850–860. doi:10.1038/s41436-018-0259-2. KAT6A Syndrome: Genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants A full list of authors and affiliations appears at the end of the article. Abstract Purpose: Mutations in KAT6A have recently been identified as a cause of syndromic developmental delay.
    [Show full text]
  • The Emerging Landscape of Dynamic DNA Methylation in Early Childhood
    The emerging landscape of dynamic DNA methylation in early childhood Cheng-Jian Xu, Marc Jan Bonder, Cilla Söderhäll, Mariona Bustamante, Nour Baïz, Ulrike Gehring, Soesma Jankipersadsing, Pieter van der Vlies, Cleo van Diemen, Bianca van Rijkom, et al. To cite this version: Cheng-Jian Xu, Marc Jan Bonder, Cilla Söderhäll, Mariona Bustamante, Nour Baïz, et al.. The emerg- ing landscape of dynamic DNA methylation in early childhood. BMC Genomics, BioMed Central, 2017, 18, pp.25. 10.1186/s12864-016-3452-1. hal-01792686 HAL Id: hal-01792686 https://hal.archives-ouvertes.fr/hal-01792686 Submitted on 26 May 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Xu et al. BMC Genomics (2017) 18:25 DOI 10.1186/s12864-016-3452-1 RESEARCHARTICLE Open Access The emerging landscape of dynamic DNA methylation in early childhood Cheng-Jian Xu1,2*, Marc Jan Bonder2, Cilla Söderhäll3,4, Mariona Bustamante5,6,7,8, Nour Baïz9, Ulrike Gehring10, Soesma A. Jankipersadsing1,2, Pieter van der Vlies2, Cleo C. van Diemen2, Bianca van Rijkom2, Jocelyne Just9,11, Inger Kull12, Juha Kere3,13, Josep Maria Antó5,7,8,14, Jean Bousquet15,16,17,18, Alexandra Zhernakova2, Cisca Wijmenga2, Isabella Annesi-Maesano9, Jordi Sunyer5,7,8,14, Erik Melén19, Yang Li2*, Dirkje S.
    [Show full text]
  • Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity Received: 11 November 2016 Audrey E
    www.nature.com/scientificreports OPEN Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity Received: 11 November 2016 Audrey E. Hendricks1,2, Elena G. Bochukova3,4, Gaëlle Marenne1, Julia M. Keogh3, Neli Accepted: 10 April 2017 Atanassova3, Rebecca Bounds3, Eleanor Wheeler1, Vanisha Mistry3, Elana Henning3, Published: xx xx xxxx Understanding Society Scientific Group*, Antje Körner5,6, Dawn Muddyman1, Shane McCarthy1, Anke Hinney7, Johannes Hebebrand7, Robert A. Scott8, Claudia Langenberg8, Nick J. Wareham8, Praveen Surendran9, Joanna M. Howson9, Adam S. Butterworth9,10, John Danesh1,9,10, EPIC-CVD Consortium*, Børge G Nordestgaard11,12, Sune F Nielsen11,12, Shoaib Afzal11,12, SofiaPa padia3, SofieAshford 3, Sumedha Garg3, Glenn L. Millhauser13, Rafael I. Palomino13, Alexandra Kwasniewska3, Ioanna Tachmazidou1, Stephen O’Rahilly3, Eleftheria Zeggini1, UK10K Consortium*, Inês Barroso1,3 & I. Sadaf Farooqi3 Obesity is a genetically heterogeneous disorder. Using targeted and whole-exome sequencing, we studied 32 human and 87 rodent obesity genes in 2,548 severely obese children and 1,117 controls. We identified 52 variants contributing to obesity in 2% of cases including multiple novel variants in GNAS, which were sometimes found with accelerated growth rather than short stature as described previously. Nominally significant associations were found for rare functional variants inBBS1 , BBS9, GNAS, MKKS, CLOCK and ANGPTL6. The p.S284X variant in ANGPTL6 drives the association signal (rs201622589, MAF~0.1%, odds ratio = 10.13, p-value = 0.042) and results in complete loss of secretion in cells. Further analysis including additional case-control studies and population controls (N = 260,642) did not support association of this variant with obesity (odds ratio = 2.34, p-value = 2.59 × 10−3), highlighting the challenges of testing rare variant associations and the need for very large sample sizes.
    [Show full text]
  • ONCOPANEL (Popv3)
    ONCOPANEL (POPv3) TEST INFORMATION BACKGROUND: Somatic genetic alterations in oncogenes and tumor-suppressor genes contribute to the pathogenesis and evolution of human cancers. These alterations can provide prognostic and predictive information and stratify cancers for targeted therapeutic information. We classify these alterations into five tiers using the following guidelines: Tier 1: The alteration has well-established published evidence confirming clinical utility in this tumor type, in at least one of the following contexts: predicting response to treatment with an FDA-approved therapy; assessing prognosis; establishing a definitive diagnosis; or conferring an inherited increased risk of cancer to this patient and family. Tier 2: The alteration may have clinical utility in at least one of the following contexts: selection of an investigational therapy in clinical trials for this cancer type; limited evidence of prognostic association; supportive of a specific diagnosis; proven association of response to treatment with an FDA-approved therapy in a different type of cancer; or similar to a different mutation with a proven association with response to treatment with an FDA-approved therapyin this type of cancer. Tier 3: The alteration is of uncertain clinical utility, but may have a role as suggested by at least one of the following: demonstration of association with response to treatment in this cancer type in preclinical studies (e.g., in vitro studies or animal models); alteration in a biochemical pathway that has other known, therapeutically-targetable alterations; alteration in a highly conserved region of the protein predicted, in silico, to alter protein function; or selection of an investigational therapy for a different cancer type.
    [Show full text]
  • A 10-Year-Old Girl with Joubert Syndrome and Chronic Kidney Disease and Its Related Complications
    4226 Letter to the Editor A 10-year-old girl with Joubert syndrome and chronic kidney disease and its related complications Chong Tian1#, Jiaxiang Chen1,2#, Xing Ming1, Xianchun Zeng1, Rongpin Wang1 1Department of Medical Imaging, Guizhou Provincial People’s Hospital, Guiyang, China; 2Guizhou University School of Medicine, Guiyang, China #These authors contributed equally to this work. Correspondence to: Rongpin Wang. Department of Medical Imaging, Guizhou Provincial People’s Hospital, Zhongshan East Road 83, Guiyang 550002, China. Email: [email protected]. Submitted Aug 05, 2020. Accepted for publication Apr 01, 2021. doi: 10.21037/qims-20-943 View this article at: http://dx.doi.org/10.21037/qims-20-943 Introduction and ankles was tolerated without redness, swelling, fistula, or sinus tract surrounding the skin. She had been healthy in Joubert syndrome (JS) is a rare genetic disorder of recessive the past, and her academic performance was moderate. She neurodevelopmental disorder characterized by distinctive was a picky eater and had a mild short stature but showed cerebellar vermis and mid-hindbrain hypoplasia/dysplasia no other development dysplasia. Nystagmus, oculomotor called the “molar tooth sign” (MTS) (1). Patients present apraxia, hypotonia, and abnormal breathing patterns were with symptoms characteristic of hypotonia in infancy not observed. Concerning the patient’s family history, her and later develop ataxia, ocular motor apraxia, and may mother and father appeared normal, but their first child died also present with developmental delays or intellectual retardation. Defined by the central nervous system features, of renal failure at the age of 4, their second-born twin sons JS also affects many other organs, such as the kidneys, liver, died in the perinatal period (causes unknown), and a third and bones.
    [Show full text]
  • High-Throughput Discovery of Novel Developmental Phenotypes
    High-throughput discovery of novel developmental phenotypes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Dickinson, M. E., A. M. Flenniken, X. Ji, L. Teboul, M. D. Wong, J. K. White, T. F. Meehan, et al. 2016. “High-throughput discovery of novel developmental phenotypes.” Nature 537 (7621): 508-514. doi:10.1038/nature19356. http://dx.doi.org/10.1038/nature19356. Published Version doi:10.1038/nature19356 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:32071918 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nature. Manuscript Author Author manuscript; Manuscript Author available in PMC 2017 March 14. Published in final edited form as: Nature. 2016 September 22; 537(7621): 508–514. doi:10.1038/nature19356. High-throughput discovery of novel developmental phenotypes A full list of authors and affiliations appears at the end of the article. Abstract Approximately one third of all mammalian genes are essential for life. Phenotypes resulting from mouse knockouts of these genes have provided tremendous insight into gene function and congenital disorders. As part of the International Mouse Phenotyping Consortium effort to generate and phenotypically characterize 5000 knockout mouse lines, we have identified 410 Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms #Corresponding author: [email protected].
    [Show full text]
  • Molar Tooth Sign of the Midbrain-Hindbrain Junction
    American Journal of Medical Genetics 125A:125–134 (2004) Molar Tooth Sign of the Midbrain–Hindbrain Junction: Occurrence in Multiple Distinct Syndromes Joseph G. Gleeson,1* Lesley C. Keeler,1 Melissa A. Parisi,2 Sarah E. Marsh,1 Phillip F. Chance,2 Ian A. Glass,2 John M. Graham Jr,3 Bernard L. Maria,4 A. James Barkovich,5 and William B. Dobyns6** 1Division of Pediatric Neurology, Department of Neurosciences, University of California, San Diego, California 2Division of Genetics and Development, Children’s Hospital and Regional Medical Center, University of Washington, Washington 3Medical Genetics Birth Defects Center, Ahmanson Department of Pediatrics, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California 4Department of Child Health, University of Missouri, Missouri 5Departments of Radiology, Pediatrics, Neurology, Neurosurgery, University of California, San Francisco, California 6Department of Human Genetics, University of Chicago, Illinois The Molar Tooth Sign (MTS) is defined by patients with these variants of the MTS will an abnormally deep interpeduncular fossa; be essential for localization and identifica- elongated, thick, and mal-oriented superior tion of mutant genes. ß 2003 Wiley-Liss, Inc. cerebellar peduncles; and absent or hypo- plastic cerebellar vermis that together give KEY WORDS: Joubert; molar tooth; Va´ r- the appearance of a ‘‘molar tooth’’ on axial adi–Papp; OFD-VI; COACH; brain MRI through the junction of the mid- Senior–Lo¨ ken; Dekaban– brain and hindbrain (isthmus region). It was Arima; cerebellar vermis; first described in Joubert syndrome (JS) hypotonia; ataxia; oculomo- where it is present in the vast majority of tor apraxia; kidney cysts; patients with this diagnosis.
    [Show full text]
  • Ciliopathies Gene Panel
    Ciliopathies Gene Panel Contact details Introduction Regional Genetics Service The ciliopathies are a heterogeneous group of conditions with considerable phenotypic overlap. Levels 4-6, Barclay House These inherited diseases are caused by defects in cilia; hair-like projections present on most 37 Queen Square cells, with roles in key human developmental processes via their motility and signalling functions. Ciliopathies are often lethal and multiple organ systems are affected. Ciliopathies are London, WC1N 3BH united in being genetically heterogeneous conditions and the different subtypes can share T +44 (0) 20 7762 6888 many clinical features, predominantly cystic kidney disease, but also retinal, respiratory, F +44 (0) 20 7813 8578 skeletal, hepatic and neurological defects in addition to metabolic defects, laterality defects and polydactyly. Their clinical variability can make ciliopathies hard to recognise, reflecting the ubiquity of cilia. Gene panels currently offer the best solution to tackling analysis of genetically Samples required heterogeneous conditions such as the ciliopathies. Ciliopathies affect approximately 1:2,000 5ml venous blood in plastic EDTA births. bottles (>1ml from neonates) Ciliopathies are generally inherited in an autosomal recessive manner, with some autosomal Prenatal testing must be arranged dominant and X-linked exceptions. in advance, through a Clinical Genetics department if possible. Referrals Amniotic fluid or CV samples Patients presenting with a ciliopathy; due to the phenotypic variability this could be a diverse set should be sent to Cytogenetics for of features. For guidance contact the laboratory or Dr Hannah Mitchison dissecting and culturing, with ([email protected]) / Prof Phil Beales ([email protected]) instructions to forward the sample to the Regional Molecular Genetics Referrals will be accepted from clinical geneticists and consultants in nephrology, metabolic, laboratory for analysis respiratory and retinal diseases.
    [Show full text]